Here’s the podcast of the Q&A portion of the excellent webinar with Dr. Pennell on Molecular Markers in Management of NSCLC. 

dr-pennell-molecular-markers-qa-audio-podcast

dr-pennell-molecular-markers-qa-transcript

dr-pennell-molecular-markers-qa-figures

   Obviously, people may have additional questions about this topic but who weren’t able to attend the live program.  If you’d like to ask a question about molecular markers in lung cancer after this point, Dr. Pennell and/or one of the other GRACE faculty will be happy to try to give our best answer. 

   By the way, thanks again to Response Genetics for their grant to support this educational program.

Podcast: Play in new window | Download

Related posts:

Upcoming Webinar on Molecular Markers in Advanced NSCLC: Who to Test and What to Test For? On Feb 22nd, 6:30 PM Eastern/3:30 PM Pacific, GRACE and LUNGevity Foundation wil...

Podcast of Webinar by Dr. Lecia Sequist on Acquired Resistance to Oral EGFR Inhibitors A few weeks ago, Dr. Lecia Sequist, Assistant Professor of Medicine at Harvard Medica...

Dr. Ross Camidge on ALK Inhibition, Molecular Screening, and Options after XALKORI Continuing with Dr. Ross Camidge as our focus (see yesterday’s post for ...

Details on the Debate over Who to Test and for What Molecular Markers The following is laden with personal opinion as much as actual evidence.  Feel fre...

First ASCO Highlights Podcast: Dr. Pinder on Small Cell, Early Stage NSCLC, and Mesothelioma Several weeks ago, we were fortunate enough to have Dr. Mary Pinder (alternatel...